| Weight | 1 lbs |
|---|---|
| Dimensions | 9 × 5 × 2 in |
| target | Chlamydia pneumoniae reactive IgA |
| species reactivity | Chlamydia pneumoniae |
| applications | ELISA |
| assay type | Indirect & quantitative |
| available size | 3 mL |
Chlamydia pneumoniae IgA Control Serum BC1371A
$94.00
Summary
- Virion/Serion Diagnostic Kit Control for research use (RUO)
- Chlamydia pneumoniae IgA Control Serum
- Applications: ELISA
- IgA control serum
- Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
- 3 mL
Chlamydia pneumoniae IgA Control Serum BC1371A
| target relevance |
|---|
| Organism Chlamydia pneumoniae |
| Protein names Chlamydia pneumoniae |
| Structure and strains Chlamydia pneumoniae is a species of Chlamydia, an obligate intracellular bacterium that infects humans and is a major cause of pneumonia. It was known as the Taiwan acute respiratory agent (TWAR) from the names of the two original isolates Taiwan (TW-183) and an acute respiratory isolate designated AR-39. Briefly, it was known as Chlamydophila pneumoniae, and that name is used as an alternate in some sources. In some cases, to avoid confusion, both names are given. |
| Detection and diagnosis Diagnosis of a Chlamydia pneumoniae infection is usually based on serological analysis by detection of specific serum antibodies. In the past, the microimmunofluorescence (MIF) test has been used as a reference method. However, it is increasingly replaced by species-specific ELISA tests, which allow for better standardization and automation. Seroprevalence rates rise rapidly in preschool age and reaches >50% after adolescence. Later on in life, the prevalence of C. pneumoniae increases even further due to frequently reoccurring infections and due to its propensity to lead to chronic disease. Beyond 65 years of age, seroprevalence may reach 70-100%. Seroprevalence rates for IgA are barely lower (approximately 60-70%) than for IgG |
Data
FAQ & Publications
Frequently Asked Questions
For which assay applications is the Chlamydia pneumoniae IgA Control Serum BC1371A intended?
The Chlamydia pneumoniae IgA Control Serum BC1371A is designed for use in ELISA applications, specifically as a control serum for indirect and quantitative assays.
How should the Chlamydia pneumoniae IgA Control Serum BC1371A be stored to maintain its stability?
This control serum should be stored at refrigerated temperatures between 2-8°C to preserve its integrity and ensure reliable assay performance.
Is the Chlamydia pneumoniae IgA Control Serum BC1371A compatible with SERION ELISA kits?
Yes, the serum is ready-to-use and pre-diluted specifically for compatibility with SERION ELISA classic and SERION ELISA antigen assays.
Publications
| pmid | title | authors | citation |
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.
Protocols
| relevant to this product |
|---|
| BC1371A protocol |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.